Evaluating seizures associated with novel antineoplastic agents during breast cancer treatment using the Food and Drug Administration Adverse Event Reporting System and Canada Vigilance Adverse Reaction Online Database
Yupeng Sha, Quan Yuan, Yao Qian, Xiaoming Li, Ming Niu, Yi Du, Xiaoshuan Liang, Shanshan Sun, Yige Lu, Jiguang Han · 2025
Read Evaluating seizures associated with novel antineoplastic agents during breast cancer treatment using the Food and Drug Administration Adverse Event Reporting System and Canada Vigilance Adverse Reaction Online Database by Yupeng Sha, Quan Yuan, Yao Qian, Xiaoming Li, Ming Niu, Yi Du, Xiaoshuan Liang, Shanshan Sun, Yige Lu, Jiguang Han (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12705951.txt.
Description
Yupeng Sha and colleagues check seizure reports linked to newer breast cancer drugs. Their pharmacovigilance study from twenty twenty-five mines two safety databases. American and Canadian adverse event reports span two decades. Fourteen novel agents were compared against traditional chemotherapy.
Statistical signals flagged drugs with outsized seizure reporting. Reporting odds methods suit this spontaneous report data. Signals were checked at drug and drug-class levels. Neurological harms of new agents need systematic watching at scale. Breast cancer use of these agents keeps expanding meanwhile. The study cannot prove causation from reports alone. It does tell regulators where to look harder.
Catalog record
| CREATOR | Yupeng Sha, Quan Yuan, Yao Qian, Xiaoming Li, Ming Niu, Yi Du, Xiaoshuan Liang, Shanshan Sun, Yige Lu, Jiguang Han |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |